Talk

AI-Enabled High Content Imaging: Maximizing the Promise and Minimizing the Peril

August 22, 2024

5 minutes

Maximizing the Promise and Minimizing the Peril: AI-Enabled High-Content Imaging at Spring Science

Welcome to the Spring Science blog! We are thrilled to share insights from a recent presentation by our Senior Director of Lab Operations, Will Van Trump, on the transformative potential of AI-enabled high-content imaging in drug discovery. This talk highlights the innovative strides Spring Science is making in harnessing artificial intelligence and machine learning to accelerate scientific research and drug development.

Spring Science and Our Mission

Spring Science is at the forefront of leveraging machine learning to advance scientific programs. Our mission is to enable scientists to integrate the latest AI discoveries into their research, combining drug discovery efforts with machine learning to accelerate target identification and overall drug discovery processes. We pride ourselves on being market leaders in applying AI for drug discovery, particularly in the realm of image analysis.

AI in High-Content Imaging: A Game Changer

The field of high-content imaging has seen significant advancements thanks to computer vision and artificial intelligence. These technologies have revolutionized imaging, from improving cell segmentation through unit-type architectures to digital pathology applications. Will Van Trump’s presentation delves into the specifics of AI’s role in high-content drug screens, such as cell painting.

Cell Painting: A Primer

Cell painting is a technique that uses general morphological compartment stains instead of content-specific labels. This approach allows the extraction of vast amounts of information from images using computer vision and machine learning. The process involves several steps, including image pre-processing, illumination correction, segmentation, feature extraction, normalization, and deeper analytics for model generation.

Challenges and Best Practices in AI-Enabled Imaging

Overfitting is a common issue in machine learning, where a model trained with too many parameters becomes too specialized to the training set, losing its ability to generalize to new data. Will discusses strategies to avoid overfitting and emphasizes the importance of data diversity and normalization. Proper feature extraction is crucial, with convolutional neural networks (CNNs) offering superior performance by leveraging transfer learning from pre-trained models.

Normalization and Batch Effects

Normalization is vital to mitigate batch effects in data analysis. Techniques such as Z-score adjustments using negative controls can enhance data quality by reducing variability across different experimental plates. Will illustrates how proper normalization leads to better separation and clustering of control compounds, crucial for accurate analysis.

Assay Design and Execution: Key Considerations

Effective assay design and execution are foundational to successful high-content imaging. Considerations include sample type, plate selection, surface modifications, and consistent imaging conditions. Understanding the impact of these variables helps in designing robust experiments that yield reliable data for AI models.

Control Layout and Data Quality

The layout of control wells on plates can significantly affect data normalization and quality. An optimal design includes ample controls distributed throughout the plate, enabling better modeling and adjustment for plate gradients. Proper placement of negative controls ensures high-quality data normalization, essential for accurate analysis.


Conclusion: Leading the Way in AI-Driven Drug Discovery

Spring Science continues to lead the industry in applying AI to drug discovery. Our commitment to integrating cutting-edge AI techniques with high-content imaging positions us as market leaders, driving innovation and accelerating scientific breakthroughs. For more in-depth information on our work and the latest advancements, visit our website.

Join Us on the Cutting Edge

Stay tuned for more insights and updates from Spring Science as we continue to push the boundaries of what's possible with AI in drug discovery. Thank you for joining us on this exciting journey!


Ready to get started?

Try out our tools with your existing workflow, or we can create a custom experience for you.

For industry

Spring tools are licensed by pharma, biotechs, startups, and research groups of all kinds.

For academics

We make it easy for academic research groups and non-profits to try Spring's tools.

For educators

Educators are invited to use Spring in the classroom and with their research students.

Ready to get started?

Try out our tools with your existing workflow, or we can create a custom experience for you.

Ready to get started?

Try out our tools with your existing workflow, or we can create a custom experience for you.

For industry

Spring tools are licensed by pharma, biotechs, startups, and research groups of all kinds.

For academics

We make it easy for academic research groups and non-profits to try Spring's tools.

Ready to get started?

Try out our tools with your existing workflow, or we can create a custom experience for you.

PARTNERSHIPS

Spring's tech is used by a range of partners across biotech, pharma, and academic research. We provide both strategic collaborations and software licensing.

© 2023 Spring Discovery.

All rights reserved.

Ready to get started?

Try out our tools with your existing workflow, or we can create a custom experience for you.

PARTNERSHIPS

Spring's tech is used by a range of partners across biotech, pharma, and academic research. We provide both strategic collaborations and software licensing.

© 2023 Spring Discovery.

All rights reserved.